Probiotics for an ageing brain and muscles: the signal is there but it is thin

Keeping the brain sharp and the muscles working is the core of what most people mean by healthy ageing, and both tend to decline in later life. A growing body of research suggests the community of microbes living in the gut may influence brain and muscle physiology, which raises an appealing possibility: could swallowing live microorganisms support both? Probiotic products are widely sold with broad wellness promises, so the question of whether randomised trials actually back cognitive or physical benefits in older adults is worth answering carefully rather than assuming.

The researchers systematically reviewed randomised placebo-controlled trials of probiotics, synbiotics or faecal microbiota transplantation in populations with a mean age of at least 60 years, searching MEDLINE, Embase, Web of Science and the Cochrane Library under a pre-registered protocol. Twenty-four trials involving 1,809 participants were included, of which 20 evaluated cognitive outcomes and four evaluated muscle-related outcomes. Eleven unique studies contributed to at least one pooled analysis, which was only run when at least three sufficiently comparable studies or comparisons existed.

The pooled estimate for Mini-Mental State Examination scores was positive overall, but the trials disagreed with each other to a striking degree. In exploratory subgroup analyses the effect was positive in Alzheimer's disease but not statistically significant in broader cognitive impairment, and the difference between those subgroups was itself not significant. A second cognitive battery showed no significant pooled effect. Handgrip strength showed a modest positive estimate, but removing one study weakened it to non-significance. No eligible faecal microbiota transplantation trial was found, so all the evidence comes from probiotic and synbiotic studies.

This review supports the broad idea that the gut may talk to the brain and muscles, but it also shows how far the human trial evidence lags behind the enthusiasm. The signals it found are short-term, rest on a small evidence base, and are sensitive to individual studies, with the strongest subgroup finding coming from very few trials. The open questions are substantial: whether effects hold in healthy older adults rather than those with Alzheimer's disease, whether they persist beyond short follow-up, and which specific organisms, if any, matter.

If you have seen probiotics pitched as a healthy-ageing supplement for memory or strength, this is the honest state of the science: some encouraging early signals, none of them stable enough to count on. The cognitive findings lean heavily on trials in people with Alzheimer's disease, which may not say much about a healthy sixty-something. For now this is a topic to watch rather than a benefit to expect, and the reviewers' own conclusion is that firm efficacy claims are premature.